<bill session="116" type="h" number="5239" updated="2020-09-11T21:45:10Z">
  <state datetime="2019-11-21">REFERRED</state>
  <status>
    <introduced datetime="2019-11-21"/>
  </status>
  <introduced datetime="2019-11-21"/>
  <titles>
    <title type="short" as="introduced">Prescription Drug Price Reporting Act</title>
    <title type="short" as="introduced">Prescription Drug Price Reporting Act</title>
    <title type="display">Prescription Drug Price Reporting Act</title>
    <title type="official" as="introduced">To require reporting on prescription drug expenditures under group health plans and on prescription drug price changes, and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="J000295"/>
  <cosponsors>
    <cosponsor bioguide_id="G000588" joined="2019-12-19"/>
  </cosponsors>
  <actions>
    <action datetime="2019-11-21">
      <text>Introduced in House</text>
    </action>
    <action datetime="2019-11-21" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2019-11-22">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="HSIF" name="House Energy and Commerce" activity="Referral"/>
    <committee subcommittee="Health" code="HSIF14" name="House Energy and Commerce" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill type="s" session="116" relation="unknown" number="1664"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Business records"/>
    <term name="Federal preemption"/>
    <term name="Government information and archives"/>
    <term name="Health care costs and insurance"/>
    <term name="Inflation and prices"/>
    <term name="Prescription drugs"/>
    <term name="Retail and wholesale trades"/>
    <term name="State and local government operations"/>
  </subjects>
  <amendments/>
  <summary date="2019-11-21T05:00:00Z" status="Introduced in House">Prescription Drug Price Reporting ActThis bill requires that all prescription drug manufacturers submit certain information for every drug marketed in the United States to the Department of Health and Human Services (HHS). Specifically, manufacturers must provide information about cost, pricing, and rebates. Manufacturers are also required to submit any price changes to a prescription drug at least 30 days in advance.HHS must make this information available through a public database that enables consumers to subscribe to price change notifications for different types of prescriptions drugs.</summary>
  <committee-reports/>
</bill>
